US Has Opportunity To Lead On Ophthalmic Biosimilars

Cardinal Health’s Sonia Oskouei Expands On Findings Of 2022 Biosimilars Report And Acknowledges That Misinformation ‘Continues To Be A Challenge’

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.